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Abstract
Background and Purpose: Potential transplant renal allograft recipients exceed the number of donors. Our
institution now considers patients with small, unilateral, nonobstructing, incidental renal calculi for possible
renal donation. We adopted ex-vivo ureteroscopy (ExURS) to render these kidneys stone free at the time of renal
transplantation. We examined the safety and efficacy of ExURS.
Patients and Methods: After confirming a lack of significant metabolic defects on 24-hour urinalysis, 23 patients
with small nonobstructing unilateral nephrolithiasis detected on preoperative CT angiography underwent donor
nephrectomy. Immediately after cold perfusion, ExURS was performed with ice cold saline irrigation. Retro-
spective review was performed.
Results: Pyeloscopy was successfully performed in all 23 patients. A total of 28 calculi, mean largest diameter
3.9mm (range 3–6mm), were visualized in 19 kidneys. Basket extraction and holmium laser lithotripsy was
performed in 12 and 6 kidneys, respectively. Treatment rendered 17/19 stone-containing kidneys stone free with
a mean treatment time of 6.2 minutes (3–10min). There were no intraoperative complications. Median serum
creatinine level of recipients at 1 month and 1 year were 1.4 – 1.8mg/dL and 1.3 – 0.6mg/dL, respectively. At a
median follow-up of 63 – 47.2 months, there were no transplant urinary calculi among the recipients.
Conclusions: ExURS safely renders live donor kidney allografts stone free with low risk of recurrence. When
used appropriately, ExURS could safely increase the number of potential kidney donors and minimize the risk of
adverse stone events.
Introduction
In 2009, 16,829 kidney transplantswere performed in theUnited States, including 6387 from live donors. Despite this,
at the time of writing this article, 85,958 patients remain on the
wait list for renal transplantation (United Network for Organ
Sharing/Organ Procurement and Transplantation Network
data). A history of urolithiasis in the potential live donor has
been considered a relative contraindication to organ donation.
In 1996, the American Society of Transplant Physicians
published practice guidelines suggesting that potential do-
nors with a history of passing a single stone with a stone-free
interval of at least 10 years, low metabolic risk on 24-hour
urine analysis, and negative preoperative imaging with in-
travenous urography may be considered for donor nephrec-
tomy.1 The adoption of CT angiography for preoperative
screening, however, has resulted in patients who are other-
wise suitable donors being identified with incidental small
unilateral asymptomatic nephrolithiasis. Routine CT angiog-
raphy for screening of potential donors has been associated
with an increase in the number of patients excluded for ra-
diographic findings (16%) compared with traditional modal-
ities, including intravenous urography, renal arteriography,
and renal scan (7%), of which 42% were excluded for ne-
phrolithiasis on CT compared with 20% with conventional
imaging.2
Although these patients may be considered nonideal do-
nors, because of the relative scarcity of available organs, many
centers, including our own, have begun considering such
patients for live donor nephrectomy. A recent survey of US
renal transplant centers suggests that more than 75% of cen-
ters now consider some patients with a history of ne-
phrolithiasis as live-donor candidates.3
The optimal management of stone-bearing kidneys at
transplant is unknown. Some centers have opted for a con-
servative approach using close observation, anticipating
spontaneous passage. Stone-free rates have ranged from
*60% to 100% for stones < 4mm in small serieswith < 2 years
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mean follow-up.4,5 Conversely, Klingler and colleagues6
noted the development of ureteral obstruction after trans-
plantation of stone-containing kidneys in 4/5 patients neces-
sitating nephrostomy tube placement, including all patients
with calculi > 4mm.6 Endoscopic extraction immediately af-
ter donor nephrectomy is another option that has been pre-
viously described with minimal risk of recurrence.7,8 We
report our experience with stone retrieval using ex-vivo ur-
eteroscopy (ExURS) at the time of live donor nephrectomy for
preoperatively identified small asymptomatic renal calculi.7
Materials and Methods
After obtaining Institutional Review Board approval, 23
potential living renal donors were identified with incidental
small unilateral renal calculi on preoperative screening CT
angiography between 1996 and 2010. Any history of symp-
tomatic urolithiasis, bilateral nephrolithiasis, or incidental
stone > 1 cm precluded patients from consideration of possible
kidney donation. All donors subsequently underwent 24-hour
urinalysis andwere noted to be free ofmetabolic risk factors for
urolithiasis (hypercalciuria, hypocitraturia, hyperuricosuria,
hyperoxuluria). In addition, donors had negative screening
results for other metabolic risk factors, including gout, hyper-
parathyroidism, and hypophosphatemia.
All donors were extensively counseled about the risks of
nephrolithiasis developing in a solitary kidney after donor
nephrectomy. Similarly, all recipients were counseled about
the risk of recurrent urolithiasis developing in their dener-
vated transplanted kidney and the need to self-monitor for
signs and symptoms of recurrent urolithiasis, including he-
maturia and anuria.
Demographic data were obtained from donor and recipi-
ents including age, sex, location and number stones, stone
size, ExURS technique, operative time, intraoperative and
postoperative complications, stone-free status, stone recur-
rence in both donor and recipient, and renal allograft function.
Donor nephrectomy and renal transplantation
Reflecting practice pattern changes throughout the dura-
tion of the study, donor nephrectomywas performed using an
open flank approach in 8 cases, an intraperitoneal hand-
assisted laparoscopic approach in 12 cases, and a straight
laparoscopic intraperitoneal approach in 3, of which 1 needed
conversion to an open approach for adherent fat. Renal
transplantation was performed by a separate transplant team
in the usual manner, with the neoureterocystotomy per-
formed using the preferred technique of the transplant
surgeon. Stent placement was performed at the discretion of
the transplant surgeon or if there was concern for residual
stone fragments or significant edema of the ureteral stump.
All patients were maintained on a cyclosporine/tacrolimus
based triple drug immunosuppression regimen managed by
transplant nephrology staff.
Ex-vivo ureteroscopy
Immediately after donor nephrectomy, the harvested organ
was placed in ice, was flushed and perfused, and prepared for
transplant per our institutional protocol. While keeping the
kidney and ureter submersed in ice-cold preservation solu-
tion, ExURS was then performed by inserting the uretero-
scope into the ureteral stump and advancing into the renal
pelvis under direct vision. The kidney was then manipulated
with the nondominant hand to align the calix of interest along
the axis of the ureteroscope to minimize trauma to the pro-
cured organ (Fig. 1). Ice-cold physiologic saline irrigation was
used throughout the procedure to ensure cold ischemia.
Except for the first patient, ExURS was performed without
dilation of the ureteral stump. In two patients, including the
first patient, a flexible 9.5F ureteroscope was used. In all
others, a semirigid 6.9F ureteroscope was used. In all cases,
stones were identified under direct vision and managed with
either basket extraction or holmium laser lithotripsy. After
completion of ExURS, the kidney was provided to the trans-
plant team for transplantation.
Results
A total of 23 patients with asymptomatic small non-
obstructing nephrolithiasis identified on preoperative CT
angiography underwent ipsilateral donor nephrectomy
and ExURS (Table 1). The mean age of the donors and re-
cipients was 44.0 years(range 24– 67 y) and 41.5 years (3–72),
FIG. 1. (A) Harvested kidney with in situ calculus. Rotating the freed harvested kidney and ureter to align the afflicted calix
in the axis of the ureteroscope allows equal, atraumatic access to both the upper pole (B) and lower pole (C) to facilitate
successful endoscopic treatment.
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respectively. These patients accounted for 15 living related
and 8 living unrelated transplants. On preoperative imaging,
a total of 32 donor stones were identified, with a mean of 1.4
(1–3) stones per donor and largest stone mean size of 3.9mm
(2–6mm). Urolithiasis was not the etiology of end-stage renal
disease in any of the recipients.
The collecting system was successfully accessed in all cases
(Table 2). Dilation of the ureteral stump was performed to 20F
in the initial patient, but was not determined to be necessary
and was not performed in subsequent patients. A 6.9F semi-
rigid ureteroscope was used in 21 patients and a flexible
ureteroscope was used in the remaining two. In four patients,
no stones were visualized, consistent with either spontaneous
passage of their stone before donor nephrectomy or the calci-
fication seen on CTwas intraparenchymal. In the remaining 19
patients, a total of 28 stones were visualized, of which 4 were
intrapapillary and left in situ. Endoluminal basketingwas used
in 12 patients, and holmium:yttrium-aluminum-garnet laser
lithotripsy was used in 6 patients to successfully remove/
fragment 22/24 intracollecting system stones. Overall, 17/19
stone-bearing kidneys were stone free after ExURS. The stone
failureswere the result of one case each of infundibular stenosis
of the stone-containing calix and narrow-mouthed caliceal di-
verticulum. Mean operative time was 6.2 minutes (3–10min).
No intraoperative complications were observed. Ureteral
stents were placed at the time of transplant in 13/23 recipients
at the discretion of the transplant surgeon and were removed
at a median of 40– 17.0 days. Postoperatively, there was one
ureteral complication: Complete occlusion of the ureter-
oneocystotomy in a ureter without a stent. The patient un-
derwent exploration and revision of the ureteroneocystotomy
on postoperative day 4 and subsequently did well. Non-
urologic Clavien class II or greater complications included
wound cellulitis in one patient, lymphocele necessitating
drainage in three patients, and death secondary to fatal ar-
rhythmia/myocardial infarction just hours after transplant.9
Before death, the patient was noted to have good urine output
from the transplanted kidney.
Overall, recipients had adequate graft function with a
median serum creatinine level of 1.4 – 1.8mg/dL on postop-
erative day 30 and 1.3 – 0.6mg/dL 1 year after transplant.
One patient had delayed graft function necessitating tempo-
rary hemodialysis. One patient needed transplant nephrec-
tomy 18 months after transplant secondary to chronic
rejectionm and an additional patient needed retransplant 104
months after ExURS for chronic rejection.
Postoperative imaging studies (ultrasonography, plain ra-
diography, and CT) were performed in all patients and re-
viewed to assess stone clearance and reformation. At a
median follow-up of 63 – 47.2 months, there have been no
stone recurrences among transplant recipients. Likewise,
there have been no delayed ureteral strictures among recipi-
ents.
Discussion
Routine preoperative CT angiography for screening of
potential candidates for donor nephrectomy has been asso-
ciated with an increase in the number of patients excluded for
radiographic findings compared with traditional imaging
modalities. Of these patients, greater than 40% are excluded
for nephrolithiasis.2 Although previously a relative contrain-
dication to live donor nephrectomy because of the perceived
risk of the development of recurrent urolithiasis in the re-
maining solitary kidney of the donor aswell as the denervated
transplanted kidney, more than 75% of transplant centers
now consider certain patients with donor lithiasis for donor
nephrectomy in an effort to increase the availability of donor
kidneys to meet unmet demand for renal transplantation.3 At
our institution, we consider patients who are found to have
small, < 1 cm, unilateral incidental renal calculi on screening
CT angiography, with no history of symptomatic urolithiasis,
and normal 24-hour urine analysis for donor nephrectomy.
Still, the long-term risk to graft function and optimal man-
agement of urolithiasis in renal transplantation is not well
described.
The development of de novo urolithiasis in transplant
kidneys is thought to occur in approximately 1% of renal
transplants, with the literature reporting a range of 0.2% to
1.8%.10–12 Successful treatment of transplant lithiasis using
shockwave lithotripsy (SWL) with the patient in the prone
position was first reported in 1991.13 More recently, three
studies have been published with 5, 8, and 13 patients
demonstrating stone-free rates of 38% to 100% after a single
treatment of SWL with the patient in the prone posi-
tion.6,14,15 The pelvic location of the transplanted kidney,
however, may adversely affect stone localization and tar-
geting during SWL, hindering its effectiveness. Access to the
Table 1. Patient Demographics
Donor Recipient
Mean Range Mean Range
Age (y) 44.0 24–67 41.5 3–72
Male:female 8:15 13:10
Largest stone size (mm) 3.9 2–6
No. stones 1.4 1–3
Visualized stone location Number
Upper pole 5
Midpole 10
Lower pole 13
Table 2. Ex-Vivo Ureteroscopy Outcomes
Outcome Number %
Collecting systems accessed 23/23 100
Kidneys with visualized stones 19/23 86.4
Intracollecting systems stones treated 22/24 91.7
Kidneys rendered stone free 17/19 89.5
Ureteral stents 13/23 56.5
Mean Range
Operative time (min) 6.2 3–16
Treatment technique Number
Holmium laser lithotripsy 6
Endoluminal basketing 12
Negative ureteroscoy 4
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transplant ureter via a retrograde ureteroscopic approach is
often compromised. As a result, a number of groups have
reported their experience with transplant percutaneous ne-
phrostolithotomy for management of transplant urolithiasis.
Three recent studies have demonstrated stone-free rates of
76.9% to 100% after a single procedure with no documented
effects on allograft function.16–18
These studies, however, focus on management of de novo
transplant lithiasis, not in situ donor gifted lithiasis. The risk of
recurrent stone formation in donor gifted lithiasis is not well
documented. Furthermore, the evidence guiding optimal
management of donor gifted lithiasis is sparse. Some centers
have reported their experience using a conservative approach
of close observation. Martin and associates4 reported ob-
serving five patients with donor gifted lithiasis < 4mm with
spontaneous passage of 5/8 stones on follow-up CT imaging
at a mean of 711 days, rendering 3/5 (60%) patients stone free
without complications. Similarly, Devasia and coworkers5
reported spontaneous passage of < 4mm calculi in 3/3 pa-
tients on follow-up ultrasonography, with no complications
and no recurrences at 1 to 2 years of follow-up. Conversely,
Klingler and colleagues6 reported poor outcomes using non-
surgical expectant management. Of five patients receiving
kidneys with in situ donor gifted calculi, ureteral obstruction
developed in four because of stone migration, all of whom
needed emergent nephrostomy tube placement. Interestingly,
2/3 stones < 4mm resulted in the development of ureteral
obstruction.
Endoscopic extraction of in situ lithiasis in donor kidneys
at the time of transplantation using a flexible cystoscope and
pyelotomy has been successfully reported in three patients.6
At our institution, we have adopted the technique of ExURS
immediately after donor nephrectomy, first reporting our
results in 2003, which obviates the need for pyelotomy.7 Our
institution continues to use this approach, having now per-
formed ExURS in 23 patients. All such patients have been
rendered functionally stone free, with the two remaining
stones (one proximal to an infundibular stenosis and the
other contained within a narrow mouth caloceal diverticu-
lum) posing little to no risk of future obstruction. Im-
portantly, all organs have been successfully transplanted
with no recipient recurrences at more than 5 years of median
follow-up.
To protect the procured organ, we perform ExURS after
perfusion of ice-cold preservation solution, using ice-cold
saline irrigation while maintaining the organ in a bath of ice-
cold preservation solution. In our experience, ExURS adds
minimal cold ischemia time, with mean time of less than 10
minutes. Furthermore, ExURS ismuch easier than subsequent
endoscopic management because of the freedom of the non-
attached ureter and kidney. Simple manipulation of the kid-
ney and ureter to align the desired calix with the axis of the
ureteroscope allows complete access to the entire collecting
system (Fig. 1) with minimal risk of trauma to the transplant
ureter. We have found the semirigid ureteroscope to be
preferable to the flexible ureteroscope because of its shorter
length, easier navigability in the freed kidney and ureter, and
superior optics.
ExURS appears safe with no long-term ureteral or struc-
tural complications. A single episode of complete occlusion of
the transplant ureteroneocystotomy in an anastomosis with-
out stent in the immediate perioperative periodwas observed.
It is unclear if ExURS contributed to the development of this
complication, or if it was related to a technical aspect of the
transplant itself, or ischemia of the most vulnerable portion of
the transplant ureter. Finally, renal allograft function after
ExURS does not appear to be impaired, with a median serum
creatinine level of 1.3mg/dL at 1 year post-transplant in our
recipients.
Conclusions
Our experience suggests that those patients with small,
unilateral, incidental nephrolithiasis seen on preoperative CT
angiographymay safely proceedwith organ donation. ExURS
at the time of donor nephrectomy using either endoscopic
basket extraction or holmium laser lithotripsy effectively
treats in situ calculi with minimal risk to the graft and no
observed de novo stone formation.
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Abbreviations Used
CT¼ computed tomography
ExURS¼ ex vivo ureteroscopy
SWL¼ shockwave lithotripsy
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